A detailed history of Campbell Newman Asset Management Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 109,547 shares of ZTS stock, worth $20.7 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
109,547
Previous 59,271 84.82%
Holding current value
$20.7 Million
Previous $10 Million 89.36%
% of portfolio
1.55%
Previous 0.81%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$145.54 - $178.83 $7.32 Million - $8.99 Million
50,276 Added 84.82%
109,547 $19 Million
Q1 2024

Apr 16, 2024

BUY
$165.67 - $199.94 $44,730 - $53,983
270 Added 0.46%
59,271 $10 Million
Q4 2023

Jan 24, 2024

SELL
$151.44 - $200.09 $227,765 - $300,935
-1,504 Reduced 2.49%
59,001 $11.6 Million
Q3 2023

Oct 19, 2023

BUY
$167.14 - $192.77 $10.1 Million - $11.7 Million
60,505 New
60,505 $10.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $88.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.